Mechanisms of action of anti-platelet agents
Carreras, L.O.
Sangre 33(6): 505-521
1988
ISSN/ISBN: 0036-4355 PMID: 3073536 Document Number: 316404
Document emailed within 1 workday
Related Documents
Sundin, C.; Elofsson, M.; Wolf-Watz, H.; Rosell, S. 2009: Virulence blocking antibiotics. Anti-bacterial agents with completely new action mechanisms Lakartidningen 106(40): 2543-2545Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Yasunaga, K. 1978: Clinical application and evaluation of anti-platelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 36(12): 3884-3894
Gorin, N.C.; Fraitag, B.; Feldman, A.; Vallot, T.; Couturier, J.Y.; Najman, A.; Duhamel, G. 1977: Moschowitz's disease: efficacy of anti-platelet aggregation agents La Nouvelle Presse Medicale 6(42): 3959-3961
Matsuda, T. 1987: Monitoring of the action of anti-platelet agent Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 71: 235-240
Adnan Abdalla; Mazur, N.A.; Shestakova, N.V. 1991: Mechanisms of interactions of anti-arrhythmia agents during their combined use Kardiologiia 31(2): 87-91
Ogawa, S.; Naruse, T. 1981: Effects of various anti-platelet drugs and defibrinating agents on experimental glomerulonephritis in rats Nihon Jinzo Gakkai Shi 23(3): 309-322
Churiukanov, V.V. 1998: Analgesic agents: comparative evaluation, mechanisms of action, prospects Anesteziologiia i Reanimatologiia 5: 4-11
Bjørnstad, H.; Refsum, H. 1991: Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(26): 3187-3189
Nagayama, D.; Shirai, K. 2009: Action mechanisms of anti-obesity drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 67(2): 385-391
Soresi, S.; Togias, A. 2006: Mechanisms of action of anti-immunoglobulin e therapy Allergy and Asthma Proceedings 27(2 Suppl 1: S15-S23
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Arjona, A.; Bartolomé, M.T.; Mata, M.; Corral, F.; Blasco, M.R.; Jiménez, C. 1997: Idiopathic multiple cerebral hemorrhage: are platelet anti-aggregation agents a risk factor? Revista de Neurologia 25(148): 2069
Troll, W.; Frenkel, K.; Wiesner, R. 1987: Protease inhibitors: possible preventive agents of various types of cancer and their mechanisms of action Progress in Clinical and Biological Research 239: 297-315
Caminero, A.B.; Frank, A.; Barreiro, P.; Díez Tejedor, E. 1995: Nootropic agents: a review of their pharmacological properties, mechanisms of action and therapeutic uses Revista Clinica Espanola 195(3): 172-179
Orihata, M.; Sarna, S.K. 1994: Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone American Journal of Physiology 266(4 Pt 1): G665-G676
Kohno, T.; Obata, H. 2011: Mechanisms of action of therapeutic agents in the treatment of chronic pain in the spinal cord Masui. Japanese Journal of Anesthesiology 60 Suppl: S113-S120
Zebrowska-Lupina, I. 1978: Studies on the mechanisms of central action of alpha-adrenergic receptor blocking agents Polish Journal of Pharmacology and Pharmacy 30(4): 455-458
Christensen, S. 1981: The pharmacology of antihypertensive agents. Sites and mechanisms of action, side effects and contraindications Ugeskrift for Laeger 143(7): 397-403
Tu, R-Hui.; Zhong, G-Qiang.; Zeng, Z-Yu.; Wu, W-Feng.; He, Y. 2011: A meta-analysis on efficacy of anti-platelet agents and anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation Zhonghua Xin Xue Guan Bing Za Zhi 39(3): 262-267